SR

Sanjay Ramakant Nilangekar

Active Director Director DIN 10698238
DIN 10698238 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Ramakant Nilangekar

Data last updated:

Sanjay Ramakant Nilangekar is a Director at Almind Pharma Private Limited (since 2024). The company operates in Pharma.

DIN 10698238
Primary Designation Director
Industry Pharma
First Appointment 08 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Almind Pharma Private Limited U47721PN2024PTC232515
Director08 Jul 20242024Active

Board colleagues of Sanjay Ramakant Nilangekar

NameDINCompanyDesignation
Kamalesh Shivaji Nilangekar08145513Almind Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Almind Pharma Private Limited
Premium access

Shareholding and investment profile for Sanjay Ramakant Nilangekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Ramakant Nilangekar

Sanjay Ramakant Nilangekar currently holds 1 directorship: Almind Pharma Private Limited (Director, since 08 Jul 2024).

Sanjay Ramakant Nilangekar was first appointed on 08 Jul 2024 as Director at Almind Pharma Private Limited.

The current boards of Sanjay Ramakant Nilangekar's companies include Kamalesh Shivaji Nilangekar (Almind Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available